Leukemia Research Foundation Funds 12 New Investigators
The Leukemia Research Foundation distributes $1.2 million
for blood cancer research projects.
NORTHFIELD, Ill. - July 29, 2019 - PRLog -- The Leukemia Research Foundation is proud to announce blood cancer research funding for 2019-2020. Twelve, one-year grants of $100,000 each are awarded for New Investigators.
Congratulations to the following grantees.
Stephanie A. Berg, D.O. – Cardinal Bernardin Cancer Center, Loyola Medicine (Maywood, Ill.)
M. Andres Blanco, Ph.D. – University of Pennsylvania School of Veterinary Medicine
Hamza Celik, Ph.D. – Washington University School of Medicine (St. Louis, Mo.)
Steven M. Chan, M.D., Ph.D. – Princess Margaret Cancer Centre (Toronto, Canada)
Raffaella Di Micco, Ph.D. – Ospedale San Raffaele (Milan, Italy)
Daichi Inoue, M.D., Ph.D. – Institute of Biomedical Research and Innovation (IBRI)
(Kobe City, Japan)
Irum Khan, M.D. – University of Illinois at Chicago (Chicago, Ill.)
Yongsoo Kim, Ph.D. – VU University (Amsterdam, Netherlands)
Rui Lu, Ph.D. – University of Alabama (Birmingham, Ala.)
Michael Milyavsky, Ph.D. – Tel Aviv University (Tel Aviv, Israel)
Christopher Ott, Ph.D. – Massachusetts General Hospital Cancer Center (Charlestown, Mass.)
Capucine Van Rechem, Ph.D. – Stanford University School of Medicine (Stanford, Calif.)
"The mission of the Leukemia Research Foundation is to fund research into the causes of and cures for blood cancers and providing grants to New Investigators is critically important," said Executive Director Kevin Radelet.
"Each year, federal funding becomes more difficult to secure and New Investigators with fresh, groundbreaking ideas can't get the funding they need to develop the data required for greater funding from the National Institutes of Health (NIH) and other sources. Leukemia Research Foundation funding advances blood cancer science and jump starts careers for these scientists.
Each proposal was evaluated and scored using the same scoring system adhered to by the NIH. The Leukemia Research Foundation Medical Advisory Board, led by Patrick J. Stiff, M.D., director of Loyola Medicine's Division of Hematology/Oncology in Maywood, Ill., discussed each project in person that scored in the top half of the preliminary critique. Final recommendations were forwarded to the Leukemia Research Foundation for funding.
About The Leukemia Research Foundation
The Leukemia Research Foundation, a CharityNavigator.org 4-Star Charity headquartered in Northfield, Ill., is committed to funding research and providing support to people affected by blood cancers. The Leukemia Research Foundation is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. Since 1946, thousands of volunteers and 22 current volunteer chapters have helped the Foundation raise more than $80 million to fund research specifically targeting innovative scientists and physicians and offer educational and emotional support for patients.
Leukemia Research Foundation information is available at www.allbloodcancers.org, or call 847-424-0600.
Carl Alston (Director of Communications)
Leukemia Research Foundation